{"analyses":[{"ciPctValue":"95","groupDescription":"Chi-square was used to examine the relationship between treatment arm and 24-hour point prevalence abstinence at 6-months.","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":".05","pValueComment":"a priori threshold for statistical significance","statisticalMethod":"Chi-squared","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"35"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"321"},{"groupId":"OG001","value":"321"}],"units":"Participants"}],"groups":[{"description":"Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.","id":"OG000","title":"Arm I"},{"description":"Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).","id":"OG001","title":"Arm II"}],"paramType":"NUMBER","populationDescription":"Intent to treat analysis (lost to follow-up = smoker)","reportingStatus":"POSTED","timeFrame":"6-months","title":"24-hour Point Prevalence Abstinence at the 6-month Follow up","type":"PRIMARY","unitOfMeasure":"participants"}